435 related articles for article (PubMed ID: 32644836)
1. Systematic development and characterization of curcumin-loaded nanogel for topical application.
Kesharwani P; Jain A; Srivastava AK; Keshari MK
Drug Dev Ind Pharm; 2020 Sep; 46(9):1443-1457. PubMed ID: 32644836
[TBL] [Abstract][Full Text] [Related]
2. Development of Oral Lipid Based Nano-formulation of Dapagliflozin: Optimization, in vitro Characterization and ex vivo Intestinal Permeation Study.
Zafar A
J Oleo Sci; 2020; 69(11):1389-1401. PubMed ID: 33132278
[TBL] [Abstract][Full Text] [Related]
3. In vivo Antiplasmodial Activity of Curcumin-Loaded Nanostructured Lipid Carriers.
Rashidzadeh H; Salimi M; Sadighian S; Rostamizadeh K; Ramazani A
Curr Drug Deliv; 2019; 16(10):923-930. PubMed ID: 31663477
[TBL] [Abstract][Full Text] [Related]
4. Curcumin-loaded nanostructured lipid carriers prepared using Peceol™ and olive oil in photodynamic therapy: development and application in breast cancer cell line.
Kamel AE; Fadel M; Louis D
Int J Nanomedicine; 2019; 14():5073-5085. PubMed ID: 31371948
[TBL] [Abstract][Full Text] [Related]
5. A new topical formulation for psoriasis: development of methotrexate-loaded nanostructured lipid carriers.
Pinto MF; Moura CC; Nunes C; Segundo MA; Costa Lima SA; Reis S
Int J Pharm; 2014 Dec; 477(1-2):519-26. PubMed ID: 25445970
[TBL] [Abstract][Full Text] [Related]
6. Design, characterization and skin permeating potential of Fluocinolone acetonide loaded nanostructured lipid carriers for topical treatment of psoriasis.
Pradhan M; Singh D; Murthy SN; Singh MR
Steroids; 2015 Sep; 101():56-63. PubMed ID: 26049018
[TBL] [Abstract][Full Text] [Related]
7. Formulation, optimization, and in vitro evaluation of nanostructured lipid carriers for topical delivery of Apremilast.
Madan JR; Khobaragade S; Dua K; Awasthi R
Dermatol Ther; 2020 May; 33(3):e13370. PubMed ID: 32250507
[TBL] [Abstract][Full Text] [Related]
8. Curcumin-loaded lipid-hybridized cellulose nanofiber film ameliorates imiquimod-induced psoriasis-like dermatitis in mice.
Kang NW; Kim MH; Sohn SY; Kim KT; Park JH; Lee SY; Lee JY; Kim DD
Biomaterials; 2018 Nov; 182():245-258. PubMed ID: 30142524
[TBL] [Abstract][Full Text] [Related]
9. Design and dermatokinetic evaluation of Apremilast loaded nanostructured lipid carriers embedded gel for topical delivery: A potential approach for improved permeation and prolong skin deposition.
Rapalli VK; Sharma S; Roy A; Singhvi G
Colloids Surf B Biointerfaces; 2021 Oct; 206():111945. PubMed ID: 34216849
[TBL] [Abstract][Full Text] [Related]
10. Preparation and Characterization of Minoxidil Loaded Nanostructured Lipid Carriers.
Wang W; Chen L; Huang X; Shao A
AAPS PharmSciTech; 2017 Feb; 18(2):509-516. PubMed ID: 27120090
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of nisoldipine-loaded nanostructured lipid carriers and solid lipid nanoparticles for oral delivery: preparation, characterization, permeation and pharmacokinetic evaluation.
Dudhipala N; Janga KY; Gorre T
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):616-625. PubMed ID: 29688077
[TBL] [Abstract][Full Text] [Related]
12. Formulation And Evaluation Of Nanostructured Lipid Carriers (NLCs) Of 20(S)-Protopanaxadiol (PPD) By Box-Behnken Design.
Kim MH; Kim KT; Sohn SY; Lee JY; Lee CH; Yang H; Lee BK; Lee KW; Kim DD
Int J Nanomedicine; 2019; 14():8509-8520. PubMed ID: 31749618
[TBL] [Abstract][Full Text] [Related]
13. Quality by Design (QbD)-enabled development of aceclofenac loaded-nano structured lipid carriers (NLCs): An improved dermatokinetic profile for inflammatory disorder(s).
Garg NK; Sharma G; Singh B; Nirbhavane P; Tyagi RK; Shukla R; Katare OP
Int J Pharm; 2017 Jan; 517(1-2):413-431. PubMed ID: 27956192
[TBL] [Abstract][Full Text] [Related]
14. Systematic implementation of quality-by-design (QbD) to develop NSAID-loaded nanostructured lipid carriers for ocular application: preformulation screening studies and statistical hybrid-design for optimization of variables.
Rathod VR; Shah DA; Dave RH
Drug Dev Ind Pharm; 2020 Mar; 46(3):443-455. PubMed ID: 32037896
[TBL] [Abstract][Full Text] [Related]
15. Magnetic nanostructured lipid carrier for dual triggered curcumin delivery: Preparation, characterization and toxicity evaluation on isolated rat liver mitochondria.
Yoozbashi M; Rashidzadeh H; Kermanian M; Sadighian S; Hosseini MJ; Kaboli Z; Rostamizadeh K
J Biomater Appl; 2022 Jan; 36(6):1055-1063. PubMed ID: 34304637
[TBL] [Abstract][Full Text] [Related]
16. Development of Curcumin-Loaded Solid Lipid Nanoparticles Utilizing Glyceryl Monostearate as Single Lipid Using QbD Approach: Characterization and Evaluation of Anticancer Activity Against Human Breast Cancer Cell Line.
Bhatt H; Rompicharla SVK; Komanduri N; Aashma S; Paradkar S; Ghosh B; Biswas S
Curr Drug Deliv; 2018; 15(9):1271-1283. PubMed ID: 29732970
[TBL] [Abstract][Full Text] [Related]
17. Dipeptide-1 modified nanostructured lipid carrier-based hydrogel with enhanced skin retention and topical efficacy of curcumin.
Yuan M; Niu J; Li F; Ya H; Liu X; Li K; Fan Y; Zhang Q
RSC Adv; 2023 Oct; 13(42):29152-29162. PubMed ID: 37800130
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of Nanostructured Lipid Carriers Loaded Chitosan/ Carbopol Hybrid Nanocomposite Gel for Oral Delivery of Artemether and Curcumin.
Kumar A; Behl T; Uniyal T; Chadha S
Pharm Nanotechnol; 2020; 8(5):418-432. PubMed ID: 32895049
[TBL] [Abstract][Full Text] [Related]
19. Dual Nanostructured Lipid Carriers/Hydrogel System for Delivery of Curcumin for Topical Skin Applications.
Calderon-Jacinto R; Matricardi P; Gueguen V; Pavon-Djavid G; Pauthe E; Rodriguez-Ruiz V
Biomolecules; 2022 Jun; 12(6):. PubMed ID: 35740905
[TBL] [Abstract][Full Text] [Related]
20. Curcumin-loaded solid lipid nanoparticles with Brij78 and TPGS improved in vivo oral bioavailability and in situ intestinal absorption of curcumin.
Ji H; Tang J; Li M; Ren J; Zheng N; Wu L
Drug Deliv; 2016; 23(2):459-70. PubMed ID: 24892628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
